Navigation Links
Developing High-Value Competitive Intelligence Functions in the Pharmaceutical Industry

CHAPEL HILL, N.C., Nov. 8, 2013 /PRNewswire/ -- The competitive intelligence (CI) function within pharmaceutical and related industries plays an incremental role in transforming competitive data into actionable insights that have a financial impact for the company. Despite this, the CI function is still not seen as a traditional corporate function, such as Finance or Sales. Because of this, the value of the function remains poorly understood by senior leadership.

Recent research by benchmarking firm Best Practices, LLC offers critical insights for healthcare leaders on how to increase the value of their CI function. Value of the CI function is often judged by a leader's ability to 'move the needle' by producing some kind of measurable financial outcome for their company. In order to justify the function to leaders, savvy groups must measure their CI impact in financial terms that executives can understand and believe.  

The report, "How Successful Companies Create and Develop a High-Value CI Function to Drive Better Business Decisions," identifies best practices and innovative methods for improving the strategic role and impact of the CI function within the pharmaceutical and related industries. The study also identifies current trends in structuring and activities completed by the function that will allow leaders to evaluate their organization's CI function relative to other leading companies.

Key study topics covered include:

  • Sources & Activities
  • Budget & FTE Levels
  • Uses of Third Party Vendors
  • Top 5 CI Employee Skills
  • CI Evolution & Trends
  • Structure & Leadership
  • Best Practices & Lessons Learned

This benchmarking research drew participation from 35 Competitive Intelligence leaders from 32 companies in the healthcare industry. Participants represented small, midcap and large biopharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with six selected respondents to gather additional insights.

To learn more about this report, download a complimentary excerpt at

For more information on other recent primary research studies, contact us at 919.403.0251 or visit our website at

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Pharmaceutical Product Launch Spend: Developing Competitive Launch and Pre-launch Budgets to Ensure a Successful Market Entry
2. Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
3. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
4. XBiotech Announces it is Developing Therapy for MRSA
5. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
6. Global Good and AUCMA Partner to Commercialize Vaccine Storage Invention for Developing Countries
7. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
8. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
9. Foundation Venture Capital Group Invests In Company Developing Implantable Meniscus for Knee Repair
10. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
11. Report Finds Big Pharma is Doing More for Access to Medicine in Developing Countries than Two Years Ago
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... --> ... att använda SyMRI för att hitta optimal ... med multipel skleros (MS) eller hjärntumörmetastaser och ... för att kunna använda SyMRI Research Edition ... kan man generera flera konstrastbilder från en ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... ... all, Water For Empowerment ™ attracts volunteers together who want to combine ... empowering women as key stakeholders in the process. The non-profit launched its first ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and far-infrared ... traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from sustainably ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... direct sauna parts and accessories. , Sauna accessories help improve the bather experience ... and personality. From basic styles for the purist looking for simplicity in design ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, ... Union (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil ... for the opening of the 5th African Network for Drugs and Diagnostics Innovation, ...
(Date:11/25/2015)... TX (PRWEB) , ... November 25, 2015 , ... For ... the companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two ... services to aid in MAP International’s cause. , MAP International was founded in 1954 ...
Breaking Medicine News(10 mins):